Fingerprint
Dive into the research topics of 'Lenvatinib plus pembrolizumab in patients with advanced endometrial cancer: an interim analysis of a multicentre, open-label, single-arm, phase 2 trial'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically